Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid Tumors.
J Clin Med
; 11(8)2022 Apr 14.
Article
in En
| MEDLINE
| ID: mdl-35456276
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Med
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: